Table 1. Baseline characteristics of the cohort studied.
| Clinical Characteristic | Quintile | ||||
|---|---|---|---|---|---|
|
| |||||
| I | II | III | IV | V | |
|
| |||||
| Age | 61±9 | 63±9 | 62±9 | 63±9 | 63±9 |
| White | 44% | 51% | 48% | 36% | 39% |
| Black | 9% | 13% | 18% | 21% | 30% |
| Hispanic | 22% | 22% | 24% | 32% | 24% |
| Asian | 25% | 15% | 11% | 11% | 6% |
| Male | 87% | 72% | 55% | 32% | 10% |
| BMI(kg/m2) | 24±3 | 26±3 | 27±4 | 29±4 | 32±5 |
| Systolic blood pressure(mm Hg) | 117±18 | 120±19 | 121±20 | 123±20 | 126±22 |
| Anti-Hypertensive Use | 24% | 32% | 41% | 44% | 52% |
| Diabetes | 12% | 8% | 11% | 15% | 14% |
| LDL(mg/dl) | 110±29 | 113±29 | 110±30 | 116±34 | 113±34 |
| HDL(mg/dl) | 51±16 | 51±17 | 52±16 | 51±16 | 53±14 |
| Current Smoker | 15% | 13% | 13% | 5% | 9% |
| Current Alcohol Use | 63% | 58% | 60% | 48% | 39% |
| Adiponectin (ug/mL) | 20±14 | 20±13 | 19±11 | 21±14 | 19±10 |
| Leptin (ng/mL) | 2.3±1.0 | 6.3±1.4 | 12.2±2.3 | 22.8±4.3 | 51.9±27.1 |
| Leptin Measured at Exam 3 | 67% | 61% | 66% | 63% | 67% |
Values are stratified by leptin quintile and noted as mean±SD or percent of total.